Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-01-23

Clinical Trial Update: Evaluation of Birdshot Retine Choroidopathy Treatment by Either Steroid or Interferon alpha2a [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating steroids versus interferon alpha-2a for Birdshot Chorioretinopathy with cystoid macular edema; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Interferon alpha-2a (interferon alfa-2a)
  • Steroid (steroid)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Birdshot Chorioretinopathy, Cystoid Macular Edema | Phase 2 | Status: COMPLETED